Credit Suisse Downgrades Forma Therapeutics (FMTX) to Neutral
Tweet Send to a Friend
Credit Suisse analyst Tiago Fauth downgraded Forma Therapeutics (NASDAQ: FMTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
